or Try an Advanced Search...

    Technical Analysis for CRBP - Corbus Pharmaceuticals Holdings, Inc.

    Grade Last Price % Change Price Change
    B 49.40 9.17% 4.15
    CRBP closed up 9.17 percent on Monday, July 1, 2024, on approximately normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical CRBP trend table...
    Date Alert Name Type % Chg
    Crossed Above 20 DMA Bullish 0.00%
    Up 3 Days in a Row Strength 0.00%
    50 DMA Support Bullish 9.17%
    Pocket Pivot Bullish Swing Setup 9.17%
    Volume Surge Other 9.17%
    Outside Day Range Expansion 9.17%
    50 DMA Support Bullish 12.58%
    Inside Day Range Contraction 12.58%
    20 DMA Resistance Bearish 13.59%
    50 DMA Support Bullish 13.59%
    Older End-of-Day Signals for CRBP ...

       Recent Intraday Alerts

    Alert Time
    Up 10% about 5 hours ago
    Up 1 ATR about 5 hours ago
    Up 5% about 9 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    Up 3% about 9 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CRBP Chart by TradingView
    Basic chart:

    Profile

    Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel therapeutics to treat inflammatory-fibrotic diseases. The company primarily develops Resunab, an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and diffuse scleroderma. It sells its products through hearing professionals, including audiologists, hearing aid specialists, and ENT doctors worldwide. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Organ Systems Hearing Cystic Fibrosis Hearing Aid Fibrotic Disease Treatment Of Cystic Fibrosis Ajulemic Acid Channelopathies Scleroderma

    Is CRBP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 1 Cannabis Stock Movers For July 1, 2024
    Jun 11 Corbus gains ahead of Goldman Sachs event
    Jun 3 Corbus: Nectin-4 Targeting Proven With U.S. Data On The Way Early 2025
    Jun 1 Corbus outlines phase 1 results from ADC trial for bladder, cervical cancers
    Jun 1 SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024
    May 31 Cannabis Stock Gainers And Losers From May 31, 2024
    May 30 Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference
    May 27 Bearish Sentiment Across The Cannabis Space - Check Full Movers For May 27, 2024
    May 23 Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
    May 13 Corbus Pharmaceuticals a new outperform at RBC on cancer, obesity assets
    See more CRBP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 55.4099
    52 Week Low 3.0334
    Average Volume 279,166
    200-Day Moving Average 23.11
    50-Day Moving Average 43.05
    20-Day Moving Average 46.16
    10-Day Moving Average 44.31
    Average True Range 3.69
    RSI (14) 59.84
    ADX 19.4
    +DI 27.85
    -DI 17.71
    Chandelier Exit (Long, 3 ATRs) 44.34
    Chandelier Exit (Short, 3 ATRs) 51.68
    Upper Bollinger Bands 52.23
    Lower Bollinger Band 40.08
    Percent B (%b) 0.77
    BandWidth 26.33
    MACD Line 0.50
    MACD Signal Line 0.59
    MACD Histogram -0.0942
    Fundamentals Value
    Market Cap 510.64 Million
    Num Shares 10.3 Million
    EPS -11.12
    Price-to-Earnings (P/E) Ratio -4.44
    Price-to-Sales 163.32
    Price-to-Book 744.81
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 57.07
    Resistance 3 (R3) 56.40 53.18 55.79
    Resistance 2 (R2) 53.18 51.23 53.51 55.36
    Resistance 1 (R1) 51.29 50.02 52.24 51.96 54.94
    Pivot Point 48.07 48.07 48.54 48.40 48.07
    Support 1 (S1) 46.18 46.12 47.13 46.85 43.86
    Support 2 (S2) 42.96 44.91 43.29 43.44
    Support 3 (S3) 41.07 42.96 43.01
    Support 4 (S4) 41.74